Browse All
Displaying 2316 - 2320 of 2550
Author:Bove, Riley Pia Amato, Maria Dobson, Ruth M. Krysko, Kristen Stoll, Sharon Vukusic, Sandra Yamout, Bassem Zielman, Ronald Krishna Gummuluri, Swetha Jehl, Valentine Schulze Topphoff, Ulf Sullivan, Roseanne Fantaccini, Simone Hellwig, Kerstin
Session Name:P9: MS Special Populations
Topic:MS and Inflammatory Disease
Program Number:P9.014
Author Institution:UCSF Weill Institute for Neuroscience, University of California San Francisco, San Francisco, California, USA, Berkeley, CA Department NEUROFARBA, University of Florence, Florence, Italy IRCCS Fondazione Don Carlo Gnocchi, Florence, Italy, Florence, Italy Preventive Neurology Unit, Wolfson Institute of Population Health, Queen Mary University of London, London, United Kingdom Department of Neurology, Royal London Hospital, Barts Health NHS Trust, London, United Kingdom, London, United Kingdom Division of Neurology, Department of Medicine, St. Michael’s Hospital, University of Toronto, Toronto, Ontario, Canada Li Ka Shing Knowledge Institute, St. Michael’s Hospital, Toronto, Ontario, Canada, Toronto, ON, Canada Department of Neurology, Yale University, New Haven, Connecticut, USA, New Haven, CT Service de neurologie, sclérose en plaques, pathologies de la myéline et neuro-inflammation, Hôpital neurologique Pierre Wertheimer, Hospices Civils de Lyon, Lyon, France Centre des Neurosciences de Lyon, INSERM 1028 et CNRS UMR5292, Observatoire Français de la Sclérose en Plaques, Lyon, France Université Claude Bernard Lyon 1, Villeurbanne, France, BRON Cedex, France American University of Beirut Medical Center, Beirut, Lebanon Harley Street Medical Centre, Abu Dhabi, UAE, Beirut, Lebanon Novartis Pharma B.V., Amsterdam, The Netherlands, Haaksbergweg, Netherlands Novartis Healthcare Pvt Ltd, Hyderabad, India, Hyderabad, India Novartis Pharma A.G. Basel, Switzerland, Basel, Switzerland Novartis Pharma GmbH, Germany, Nuernberg, Germany Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA, East Hanover, NJ Novartis Pharma A.G. Basel, Switzerland, Binningen, Switzerland St. Josef-Hospital/Ruhr-University Bochum, Bochum, Germany, Bochum, Germany
Author:Teekaput, Chutithep Thiankhaw, Kitti
Session Name:P11: Movement Disorders: Dystonia 1
Topic:Movement Disorders
Program Number:P11.007
Author Institution:Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand Division of Neurology, Maharaj Nakorn Chiang Mai Hospital, Chiang Mai, Thailand
Author:Ailani, Jessica Charleston, Larry Albrecht, Detlef
Session Name:P13: Headache: Therapeutics 1
Topic:Headache
Program Number:P13.003
Author Institution:Medstar Georgetown Neurology, McLean, VA Michigan State University College of Human Medicine, East Lansing, MI Satsuma, San Francisco, CA
Author:Rosso, Mattia Milano, Nicholas Gleichgerrcht, Ezequiel
Session Name:P14: MS Clinical Practice
Program Number:P14.017
Author Institution:Medical University of South Carolina, Charleston, SC
Author:Villamar, Mauricio Ayub, Neishay Koenig, Seth
Session Name:S30: Epilepsy/Clinical Neurophysiology (EEG): Technology
Topic:Epilepsy/Clinical Neurophysiology (EEG)
Program Number:S30.009
Author Institution:The Warren Alpert Medical School of Brown University, Providence, RI Kent Hospital, Warwick, RI
